Collegium Pharmaceutical, Inc. earnings per share and revenue

COLL earnings per share for the last quarter are 1.45 USD whereas the estimation was 1.47 USD which accounts for -1.38% surprise. Företagets omsättning för samma period uppgår till 144.92 M USD trots den uppskattade siffran 146.94 M USD. Estimated earnings per share for the next quarter are 1.60 USD, and revenue is expected to reach 142.76 M USD. Also watch annual changes over time to get a bigger picture of COLL earnings per share and revenue dynamics.